Paola Valdez
@PaolaVS94
Followers
46
Following
119
Statuses
21
Joined December 2021
RT @BourlonMaite: The ALEBRIJE study is out!! 🇲🇽 @JCOGO_ASCO @ASCO #bladdercancer 🎉1st Mexican report: treatment trends mUC ⬆️ rates of p…
0
31
0
RT @TAMedOncol: 📖 Top-read in TAM: The development of #PARPinhibitors in advanced #ProstateCancer. Check out the comprehensive review on th…
0
9
0
RT @BourlonMaite: Our article of iPARPs in #ProstateCancer a top-read in @TAMedOncol A 🇲🇽🇪🇸collaboration @Ecastromarcos @PaolaVS94 @Bourl…
0
17
0
RT @DrChoueiri: Standing ovation for a very poignant and just beautiful opening session by @ASCOPres Dr. Lynn Schuchter “The art & science…
0
64
0
RT @BourlonMaite: Wonderful night @oncodaily Award Ceremony! It was my privilege to be part of the awards Committe 🥰🇲🇽👩🏻⚕️🌍
0
9
0
RT @BourlonMaite: Beautiful #ASCO2024 Award Ceremony by @ConquerCancerFd 🔸I was an IDEA awardee in 2013 & this year I am proud to be Chai…
0
14
0
RT @BourlonMaite: Proud @INCMNSZ_Uronco and @SMEOMX at the @JCOGO_ASCO Global Oncology Community Practice #ASCO2024 🇲🇽 🔸mUC were treated in…
0
20
0
RT @DrChoueiri: Another MAJOR development in GU Cancers presented at #EAU24. Nivolumab improves OS in bladder cancer ! This is major. First…
0
44
0
RT @BourlonMaite: Just at #gu2024 @ASCO 🔹Keynote 564! Adjuvant pembrolizumab in resected high risk RCC has OS benefit! @DrChoueiri 🔸@PBa…
0
11
0
RT @BourlonMaite: Muy contentos de ver a @INCMNSZ_Uronco en este artículo de cáncer de prostata * Gracias @PaolaVS94 y @Ecastromarcos
0
4
0
RT @DrRaul_onco: Join me in this special podcast episode where we shine a light on the progress and challenges in the fight against cancer.…
0
4
0
RT @DrYukselUrun: Exploring the Frontier of RCC Treatment: Navigating Through Adjuvant Therapy Challenges! Outstanding perspective! @Bourlo…
0
9
0
RT @JuanCaNH95: Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab @Pa…
0
1
0
RT @BourlonMaite: @ASCO Daily News Proposed algorithm! Adjuvant pembrolizumab is SOC for high-risk resected RCC 🔹Oligometastatic recurrenc…
0
34
0
RT @oncodaily: PARPi for prostate cancer @BourlonMaite
@Ecastromarcos @incmnszmx @PaolaVS94 @TAMedOncol
#oncology…
0
4
0
RT @BourlonMaite: Great! “PARPi for prostate cancer” 🔹1st targeted therapy for advanced disease ✅ TRITON-3 & PROFOUND showed benefit in mCR…
0
29
0
RT @melladoorellana: So proud to belong to this family of future oncologists. I feel a great responsability to keep building upon the progr…
0
4
0
RT @ReginaBarCar: Ten days away from finishing my Oncology fellowship @incmnszmx, and we got to do the last Grand Rounds for the academic y…
0
5
0
RT @sciencelinkonco: #Podcast #PasedeVisita Dr. Luis Alfonso Romero (@leoncologo), Dra. Perla Pérez Pérez, Dr. Pedro Andrés Valero Morales…
0
3
0